CASTELEIN CALEY received a stock award from WHITEHAWK THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2025ACC: 0001415889-25-006742
Director
Since Sep 2018
+1.67M
Net shares
Net buyer
$4.00M
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.67M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.67M
Price / share
$2.40
Trade value
$4M
% of position
333.2%
3/4/2025
500K→2.17M
Total
Net shares
+1.67M
Net value
$4M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/4/2025 | A · Award | +1.67M | $2.40 | $4M | 333.2% | 500K | 2.17M |
| Total | +1.67M | $4M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned19.69K
Total
19.69K direct19.69K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 19.69K | Direct |
| Total | 19.69K | 19.69K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported